Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial
Philippe Maeder
International Journal of Radiation Oncology*Biology*Physics, 2006
View PDFchevron_right
Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma
Sanjeev Chawla, PhD. DABMP
Journal of Magnetic Resonance Imaging, 2020
View PDFchevron_right
Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas
William Scotton
Journal of magnetic resonance imaging : JMRI, 2015
View PDFchevron_right
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
Bella Vakulenko-Lagun
Scientific Reports
View PDFchevron_right
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques
Ruben Emanuel Nechifor
Frontiers in Oncology, 2022
View PDFchevron_right
Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results
Domenico Catapano
Journal of experimental & clinical cancer research : CR, 2006
View PDFchevron_right
Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma
Benjamin Ellingson
Tomography : a journal for imaging research, 2015
View PDFchevron_right
Advanced Multiparametric Imaging for Response Assessment to Tumor-Treating Fields in Patients with Glioblastoma
Sanjeev Chawla, PhD. DABMP
2019
View PDFchevron_right
Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy
Michael Brada
BRITISH JOURNAL OF CANCER, 2004
View PDFchevron_right
Advanced Magnetic Resonance Imaging in the Evaluation of Treated Glioblastoma: A Pictorial Essay
Matia Martucci
Cancers
View PDFchevron_right
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
Michael Pinkawa
Journal of Nuclear Medicine, 2012
View PDFchevron_right
Perspective on the EF-14 trial and its implications for the role of tumor-treating fields in the management of glioblastoma
Sanjeev Chawla, PhD. DABMP
Translational Cancer Research, 2016
View PDFchevron_right
Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen
Michael Schroeter
Journal of Neuro-Oncology, 2009
View PDFchevron_right
Assessment of Early Therapeutic Response to Nitroxoline in Temozolomide-Resistant Glioblastoma by Amide Proton Transfer Imaging: A Preliminary Comparative Study with Diffusion-weighted Imaging
Nisha Kumari
Scientific Reports
View PDFchevron_right
P14.66 TTFields dose distribution and tumor growth patterns confirm clinical activity of TTFields: MRI analysis of the randomized phase 3 EF-14 trial
Andreas Hottinger
Neuro-Oncology, 2019
View PDFchevron_right
Quantitative evaluation of diffusion tensor imaging for clinical management of glioma
Shalini Tripathi
Neurosurgical Review, 2018
View PDFchevron_right
MRI in treatment of adult gliomas
gilberto gonzalez
The Lancet Oncology, 2005
View PDFchevron_right
Glioblastoma: A Method for Predicting Response to Antiangiogenic Chemotherapy by Using MR Perfusion Imaging—Pilot Study 1
Wanyong Shin
Radiology, 2010
View PDFchevron_right
Detection of glioblastoma response to temozolomide combined with bevacizumab based on MRI and PET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy
Elodie Pérès
Neuro-Oncology, 2013
View PDFchevron_right
Editorial: Structural, Metabolic, and Physiologic MR Imaging to Study Glioblastomas
Sanjeev Chawla, PhD. DABMP
Frontiers in Neurology, 2022
View PDFchevron_right
Evaluation of advanced MR techniques for development of early biomarkers for treatment efficacy in malignant brain tumors
Jón Hauksson
Neuro-oncology, 2010
View PDFchevron_right
A systematic review of amino acid PET in assessing treatment response to temozolomide in glioma
Christen O'Neal
Neuro-Oncology Advances, 2022
View PDFchevron_right
Daily Tracking of Glioblastoma Resection Cavity, Cerebral Edema, and Tumor Volume with MRI-Guided Radiation Therapy
Radka Stoyanova
Cureus, 2018
View PDFchevron_right
Five-Year Longitudinal MRI Follow-up and 1H Single Voxel MRS in 14 Patients with Gliomatosis Treated with Temodal, Radiotherapy and Antiangiogenic Therapy
Francois Kauffmann
The Neuroradiology Journal, 2011
View PDFchevron_right
Impact of imaging measurements on response assessment in glioblastoma clinical trials
Karla Ballman, Benjamin Ellingson
Neuro-oncology, 2014
View PDFchevron_right
Early changes in perfusion of glioblastoma during radio- and chemotherapy evaluated by T1-dynamic contrast enhanced magnetic resonance imaging
Svend Engelholm
Acta Oncologica, 2015
View PDFchevron_right
Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas
antonella iadanza
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2018
View PDFchevron_right
Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects
Peggy Provent
NMR in Biomedicine, 2011
View PDFchevron_right
High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics
Ruben Emanuel Nechifor
Frontiers in Oncology, 2022
View PDFchevron_right
Complementary but Distinct Roles for MRI and 18F-Fluoromisonidazole PET in the Assessment of Human Glioblastomas
T. Adamsen, H. Harpold
Journal of Nuclear Medicine, 2008
View PDFchevron_right
Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [18F]FLT-PET Imaging
Thomas Viel
PLoS ONE, 2013
View PDFchevron_right
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy
Benjamin Ellingson
PloS one, 2018
View PDFchevron_right